查詢結果分析
來源資料
相關文獻
- HeartMate Left Ventricular Assist Device for Long-Term Circulatory Support
- 週產期心肌病變導致體液容積過量之問題分析與護理措施
- Restrictive Cardiomyopathy in a Patient with Primary (AL) Cardiac Amyloidosis: Should Heart Transplantation be Performed﹖-- A Case Report and Review
- Single Coronary Artery--A Case Report
- 粒線體心肌病: 生化與分子生物學分析
- Status of Trace Elements in Patients with Idiopathic Dilated Cardiomyopathy in Central Taiwan
- Evolution of Dilated Cardiomyopathy from Hypertrophic Obstructive Cardiomyopathy in a Child
- Obstructive Hypertrophic Cardiomyopathy in Taiwanese Adults
- 豬肥厚性心肌病研究成果
- 心尖肥厚性心肌病變
頁籤選單縮合
題 名 | HeartMate Left Ventricular Assist Device for Long-Term Circulatory Support=以心伴式左心室輔助器長期輔助循環 |
---|---|
作 者 | 許榮彬; 朱樹勳; 簡禛彥; 柯文哲; 周迺寬; 陳益祥; 王水深; | 書刊名 | 臺灣醫學會雜誌 |
卷 期 | 99:4 2000.04[民89.04] |
頁 次 | 頁336-340 |
分類號 | 416.262 |
關鍵詞 | 心伴式左心室輔助器; 輔助循環; 心肌病; HeartMate left ventricular assist device; Cardiomyopathy; |
語 文 | 英文(English) |
英文摘要 | We describe three successful cases of HeartMate R left ventricular assist device (LVAD; Thermo Cardiosystems, Woburn, MA, USA) implantation in patients with end-stage heart failure for long-term circulatory support. Patient 1 was a 34-year- old woman with postpartum cardiomyopathy. Patients 2 and 3 were both males with dilated cardiomyopathy, 50 years and 21 years of age, respectively. They all presented in cardiogenic shock with decreased sensorium and anuria. Temporary mechanical support with an intra-aortic balloon pump or extracorporeal membrane oxygenation (ECMO) was needed for life support. Because bleeding and right ventricular failure often occur after HeartMate R LVAD implantation, we used a Vascutek tube (Vascutek Ltd, Inchinnan, Scotland) graft to wrap inflow and outflow valve conduits and ECMO as a bridge to HeartMate LVAD implantation. Following surgery, cardiac output increased from 2.70, 2.06 and 2.53 L/min to 4.50, 5.80 and 5.00 L/min in the three patients. HeartMate R LVAD can provide safe and stable long-term circulatory support without the need for anticoagulation. One of the patients remained on HeartMate R for 287 days before undergoing successful heart transplantation. Patients with HeartMate R LVAD are ambulatory and may be discharged while awaiting heart transplantation. Heart function may recover after long-term ventricular unloading with HeartMate R LVAD. |
本系統中英文摘要資訊取自各篇刊載內容。